Ajanta Pharma

Ajanta Pharma EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ajanta Pharma (AJANTPHARM.NS) as of Oct 19, 2026 is 13.94 B INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 13.54 B INR — a change of 2.94% (higher).

EBITDA

13.94 BINR

YoY

2.94%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ajanta Pharma is 2026 13.94 B INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ajanta Pharma was 2025 13.54 B INR. It decreases by 2.94% higher compared to the previous year.

The Ajanta Pharma EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
5.75 B INR
Jan 1, 2020
7.71 B INR
Jan 1, 2021
10.24 B INR
Jan 1, 2022
10.44 B INR
Jan 1, 2023
8.81 B INR
Jan 1, 2024
12.57 B INR
Jan 1, 2025
13.54 B INR
Jan 1, 2026
13.94 B INR
The Ajanta Pharma EBITDA history
YEAREBITDAYoY
13.94 BINR+2.94%
13.54 BINR+7.76%
12.57 BINR+42.56%
8.81 BINR-15.61%
10.44 BINR+2.00%
10.24 BINR+32.81%
7.71 BINR+34.06%
5.75 BINR-13.74%
6.67 BINR-8.22%
7.26 BINR+22.12%
5.95 BINR+17.74%
5.05 BINR+37.01%
3.69 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ajanta Pharma Stock analysis

What does Ajanta Pharma do? Ajanta Pharma Ltd is an Indian pharmaceutical company founded in 1973 by Madhukar Alva and has since become a leading company in the global pharmaceutical industry. Ajanta Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ajanta Pharma stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ajanta Pharma is 13.94 B INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ajanta Pharma changed from 13.54 B INR to 13.94 B INR, representing a 2.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ajanta Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ajanta Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Ajanta Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Ajanta Pharma